New hope for Parkinson's? capsule tested to slow symptoms
NCT ID NCT06596005
Summary
This study tested a new oral capsule called TJ0113 to see if it could help control the movement symptoms of early Parkinson's disease. About 150 people with early-stage Parkinson's took either TJ0113 or a placebo pill for 12 weeks. The main goal was to measure changes in movement and check the treatment's safety.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, 310009, China
Conditions
Explore the condition pages connected to this study.